Study Design: Observational
Conditions: Alagille Syndrome, Alpha 1 Anti-Trypsin Deficiency, Bile Duct Diseases, Biliary Atresia, Biliary Tract Diseases, Cholestasis, Hepatitis, Viral, Mitochondrial Disorders
Division: DDN
Duration: 2022-Ongoing
# Recruitment Centers: 14
Available Genotype Data: No
Image Summary: No
Transplant Type: Liver Transplant
Does it have dialysis patients: No
Access to biospecimens for ChiLDReN Genetic Collection Protocol (ChiLDReN-Genetics) is currently only available via collaboration. Please contact the parent study to ask about ancillary study opportunities.
Clinical Trials URL:
https://www.clinicaltrials.gov/study/NCT05272319
The purpose of this study is to establish a mechanism to collect a genetic biosample from the participants and their biological parents previously enrolled into clinical research under ChiLDReN-supported protocols, A Prospective Database of Infants with Cholestasis (PROBE, NCT00061828); Biliary Atresia Study in Infants and Children (BASIC, NCT00345553); Longitudinal Study of Genetic Causes of Intrahepatic Cholestasis (LOGIC, NCT00571272); and A Longitudinal Study of Mitochondrial Hepatopathies (MITOHEP, NCT01148550). Each of these protocols captures robust clinical longitudinal data and collects specimens to establish repositories to support future research.
The major objective of this protocol is to augment a repository of DNA from participants and their biological parents previously enrolled into clinical research but for whom a DNA biosample was not previously collected. The acquisition and storage of DNA from participants and their biological parents will make available an important resource for future and ongoing studies that may evaluate etiology, pathogenesis, biomarkers, pharmacogenomics, and genetic modifiers of these rare disorders.
None
Inclusion criteria:
Exclusion criteria:
This study is ongoing.